Metabolomic changes of the multi (-AGC-) kinase inhibitor AT13148 in cells, mice and patients are associated with NOS regulation

INTRODUCTION: To generate biomarkers of target engagement or predictive response for multi-target drugs is challenging. One such compound is the multi-AGC kinase inhibitor AT13148. Metabolic signatures of selective signal transduction inhibitors identified in preclinical models have previously been...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Akos, Asad, Yasmin, Ruddle, Ruth, Henley, Alan T., Swales, Karen, Decordova, Shaun, Eccles, Suzanne A ., Collins, Ian, Garrett, Michelle D., De Bono, Johann, Banerji, Udai, Raynaud, Florence I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154022/
https://www.ncbi.nlm.nih.gov/pubmed/32285223
http://dx.doi.org/10.1007/s11306-020-01676-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154022/
https://www.ncbi.nlm.nih.gov/pubmed/32285223
http://dx.doi.org/10.1007/s11306-020-01676-0

Ejemplares similares